Objective. To assess temporal changes in cartilage and bone morphology, reactive oxygen species (ROS), and vascularization in rats with monosodium iodoacetate (MIA)-induced osteoarthritis (OA), using advanced imaging methodologies.
Osteoarthritis (OA) is a highly prevalent and debilitating condition that affects multiple functionally integrated tissues within articular joints, including cartilage, subchondral bone, trabecular bone, synovium, and blood vessels (1) . The pathophysiologic interactions among integrated joint tissues during initiation and progression of OA are currently poorly understood.
Subchondral bone and articular cartilage are intimately related, such that alteration in one can affect the structure and functional integrity of the other (2) (3) (4) . Abnormalities in subchondral bone, such as changes in bone mineral density and bone turnover, have been suggested to contribute to the development of OA (2, (5) (6) (7) (8) . Subchondral bone serves as a passive shock absorber for the joint, blunting the effects of abnormally high mechanical loads that can damage the cartilage (9) . When subchondral bone becomes thicker and sclerotic, its shock-absorbing capacity decreases (9) . Although the exact causes of OA are currently not fully understood, a mechanical insult to the joint is regarded as a critical extrinsic risk factor (9) . Recently, studies in animal models have included longitudinal monitoring of quantitative changes in cartilage and bone (10) , which can help in elucidation of the etiopathogenesis of OA and identification of effective therapies.
In contrast to the inflammatory disorder rheumatoid arthritis, OA was formerly classified as a noninflammatory disease (11) . This concept has been recently revised, and it is now understood that synovial inflammation, or synovitis, plays a critical role in the symptoms and progression of OA (12) . Synovial inflammation, as evidenced by stiffness, pain, and effusion, is characterized by infiltration of neutrophils, T lymphocytes, and monocytes (13) and can be assessed by magnetic resonance imaging, ultrasound, arthroscopy, and biopsy (11) . The notion that synovial inflammation occurs in OA is further supported by the fact that nonsteroidal antiinflammatory drugs alleviate OA symptoms and may be more effective than simple analgesics (11, 14) . Synovitis can be induced by cartilage breakdown products, and its presence may increase the likelihood of meniscal and subchondral bone changes (15) .
Synovial inflammation is typically accompanied by angiogenesis, and both can be triggered by the same molecular events (16) . Angiogenesis is demonstrated by the growth of new blood vessels from the subchondral bone to the articular cartilage during OA progression. Inflammatory cells such as macrophages can secrete and stimulate other cells (such as endothelial cells and fibroblasts) to secrete angiogenic factors such as vascular endothelial growth factor (VEGF) (12) . Angiogenesis and synovial inflammation are closely associated in OA and may contribute to the progression of cartilage degeneration and bone remodeling (17, 18) , in part by redistributing blood vessels (19) .
The responses of individual tissues in the knee joint have been studied in the monosodium iodoacetate (MIA)-induced model of OA in the rat (20) , but quantitative assessments of changes in articular cartilage, bone, vascularization, and reactive oxygen species (ROS) have not been performed together in order to determine correlations between the affected joint tissues. The objective of this study was to assess temporal changes in multiple integrated tissues of the knee joint as well as the interactions of these tissue changes during progression of disease in rats with MIA-induced OA, using advanced imaging methodologies. Changes in 3-dimensional (3-D) cartilage morphology and composition were quantified using equilibrium partitioning of an ionic contrast agent microfocal computed tomography (EPIC-CT) imaging, changes in subchondral and trabecular bone were assessed by standard highresolution CT analysis, ROS during OA progression were characterized by in vivo fluorescence imaging, and alterations in the vascularity of knee joint tissues were quantified using CT after perfusion of a vascular contrast agent.
MATERIALS AND METHODS
Assessment of cartilage and bone. The experimental procedures used in this study were approved by the Georgia Institute of Technology Institutional Animal Care and Use Committee (protocol A06005). Anesthesia was induced in 8-week-old male Wistar rats (n ϭ 15; Charles River) by 5% isoflurane inhalation and maintained with 2% isoflurane. MIA (1 mg in 50 l saline; Sigma-Aldrich) was injected through the infrapatellar ligament of the right knee; the left knee was injected with 50 l saline as a control. Rats were killed via CO 2 inhalation at 1, 2, or 3 weeks after MIA injection (5 rats at each time point). The femora were harvested, dissected free of surrounding tissue, and stored in phosphate buffered saline (PBS) solution with 1% proteinase inhibitors (Cocktail I; Calbiochem) at 4°C (21) .
The distal femora were prescanned for bone structure prior to incubation with contrast medium. For EPIC-CT, the distal femur was then immersed in 2 ml of 40% Hexabrix 320 contrast agent (Covidien) and 60% PBS for 30 minutes at 37°C as described previously (21, 22) and gently patted dry before scanning. Samples were scanned using a CT 40 (Scanco Medical) at 45 kVp, 177 A, 200 msec integration time, and a voxel size of 16 m.
Following scanning, femora were fixed overnight in 10% neutral buffered formalin and decalcified for 10 days in 2.5% formic acid (pH 4.2). Dehydrated samples were embedded in glycol methacrylate using a JB-4 embedding kit according to the instructions of the manufacturer (Polysciences). For comparison with EPIC-CT images, sagittal sections were cut at 8 m thickness and 1 section through the center of each condyle was examined. Sections were stained for sulfated glycosaminoglycans (sGAGs) by sequential exposure to a 0.2% aqueous solution of fast green (1 minute), 1% glacial acetic acid in 70% ethanol (10 seconds), deionized water (1 minute), and 0.5% Safranin O in distilled water (5 minutes).
In vivo quantification of ROS. Eight-week-old male Wistar rats (n ϭ 5) were anesthetized by isoflurane inhalation, and 1 mg of MIA in 50 l saline was injected through the infrapatellar ligament of the right knee, with the left knee injected with saline as a control. On day 1, day 11, or day 21 after injection of MIA solution, rats were anesthetized by isoflurane inhalation, and 1 mg hydro-indocyanine green (hydro-ICG) in 50 l saline was injected intraarticularly into both knees to image ROS production. Immediately following injection, rats were allowed to recover from anesthesia and ambulate freely in their cages. A 10-day interval between sequential injections was chosen to ensure clearance of the hydro-ICG probe from the joint and return of fluorescence intensity to the baseline level. One hour after injection of the hydro-ICG solution, rats were anesthetized with isoflurane, and in vivo fluorescence images were captured using a Xenogen IVIS Lumina system (Caliper). The excitation and emission wavelengths for hydro-ICG were 745 nm and 840 nm, respectively, and the exposure time was 12 seconds.
Assessment of vascularity. Three weeks after MIA injection, the rats that were used for ROS imaging were anesthetized with isoflurane, isoflurane was maintained at the 1900 XIE ET AL induction-level dose, and the vascular systems of the rats were sequentially perfused with 0.9% physiologic saline solution, 10% neutral buffered formalin, and a lead chromate-based contrast agent (Microfil MV-122; FlowTech) via a needle passed through the left ventricle and into the aorta. This technique was slightly modified from a previously published methodology for contrast-enhanced imaging of vascular structures (23). After polymerization overnight, both knee joints were dissected to remove the attached muscles and were scanned by CT at 45 kVp, 177 A, 200 msec integration time, and a voxel size of 16 m. Following demineralization for 10 days with 10% formic acid, both knee joints and dissected femora were scanned (voxel size 16 m and 10 m, respectively). Statistical analysis. Data were expressed as the mean Ϯ SD. Cartilage and bone morphologic parameters and fluorescence intensities at different time points after MIA injection were evaluated using a one-factor (time) repeated (left versus right) generalized linear model with Tukey's test for post hoc analysis. Differences in vascularization between control and MIA-injected knees were compared by paired t-test. P values less than or equal to 0.05 were considered significant. Statistical calculations were performed with SPSS, version 11.
RESULTS
Representative images of femoral articular cartilage sections stained with Safranin O are shown in Figure 1A . At 1 week postinjection, the thickness and sGAG optical density of cartilage from rats injected with MIA were decreased compared with control cartilage from the contralateral femora. At 2 and 3 weeks postinjection, part of the subchondral bone surface was denuded without cartilage coverage, especially in loadbearing regions of the condyles of MIA-treated animals.
Figures 1B and C show representative images of 3-D morphology of rat femoral articular cartilage and bone. Consistent with our previous studies (22,24), we were able to segment cartilage from bone and therefore analyze cartilage in the 3-D EPIC-CT images. At 1 week after injection, volume and normalized thickness (volume/bone surface interface area) of cartilage from MIA-injected joints were 13% and 18% lower, respectively, than in contralateral control cartilage (P Ͻ 0.05), while cartilage attenuation was 24% higher than in control cartilage (P Ͻ 0.01) ( Figures 1B and 2 ). This suggested that sGAG content was lower in the femoral articular cartilage of MIA-treated animals (22, 24) . Trabecular bone volume fraction (bone volume/trabecular volume [BV/TV]) and trabecular thickness (TbTh) in the femoral epiphyses of MIA-treated rats were 17% and 10% lower, respectively, than in controls (P Ͻ 0.05 and P Ͻ 0.01, respectively) ( Figures 1B and 3) . At 2 weeks postinjection, femoral articular cartilage volume, area, and normalized thickness were lower in MIA-injected joints than in controls by 26% (P Ͻ 0.05), 19% (P Ͻ 0.01), and 26% (P Ͻ 0.05), respectively, and attenuation was 24% higher than in controls (P Ͻ 0.01) (Figure 2 ). An average of 12% of the surface was denuded subchondral bone with no cartilage coverage. BV/TV, connectivity density (ConnD), and TbTh in the femoral epiphyses were 22%, 26%, and 7% lower, respectively, than in controls (all P Ͻ 0.01) (Figure 3) . At 3 weeks after injection, femoral articular cartilage volume, area, and normalized thickness in MIA-injected joints were 12%, 22%, and 12% lower, respectively, than in controls (P Ͻ 0.05, P Ͻ 0.01, and P Ͻ 0.01, respectively), while attenuation was 16% higher than in controls (P Ͻ 0.01) ( Figures 1C and 2 ). An average of 14% of the surface was denuded bone without cartilage coverage. BV/TV, ConnD, and trabecular number in the femoral epiphysis were 20%, 20%, and 6% lower, respectively, in MIA-injected joints than in controls (P Ͻ 0.01, P Ͻ 0.05, and P Ͻ 0.05, respectively) (Figure 3 ).
Within joints (control or MIA injected), morphologic changes in femoral articular cartilage were seen over time, but compositional changes were not. Femoral cartilage volume and normalized thickness were significantly lower both in control and in MIA-injected joints at 2 weeks and 3 weeks postinjection compared with 1 week postinjection (in MIA-injected joints, P Ͻ 0.05 for cartilage volume and normalized thickness at 2 weeks and 3 weeks; in control joints, P Ͻ 0.05 for cartilage volume at 2 weeks, and P Ͻ 0.01 for cartilage volume at 3 weeks and for normalized thickness at 2 weeks and 3 weeks) (Figure 2 ). There was no significant difference in femoral cartilage attenuation among the 3 time points in either control or MIA-injected joints ( Figure 2D ). With MIA injection, ConnD for trabecular bone in the femoral epiphysis was lower (P Ͻ 0.05), while TbTh was higher (P Ͻ 0.05), at 2 weeks and 3 weeks compared with 1 week after injection (Figure 3 ). Representative fluorescence hydro-ICG ROS images ( Figure 4A ) demonstrated that ROS quantities were increased in the knees of rats with MIA-induced OA, and this effect lessened with increased time after MIA injection. The fluorescence intensity was 98% higher in the MIA-injected joints than in the control joints (n ϭ 5 per group) at 1 day after injection (mean Ϯ SD 1.69 Ϯ 0.25 ϫ 10 5 counts/second versus 0.86 Ϯ 0.51 ϫ 10 5 counts/second; P Ͻ 0.05) and 46% higher at 11 days after injection (1.20 Ϯ 0.27 ϫ 10 5 counts/second versus 0.82 Ϯ 0.09 ϫ 10 5 counts/second; P Ͻ 0.05) ( Figure 4B ). However, by 21 days after injection, fluorescence intensity was no longer significantly different between the 2 groups (0.54 Ϯ 0.12 ϫ10 5 counts/second versus 0.58 Ϯ 0.13 ϫ 10 5 counts/second in the MIA and control groups, respectively). Within the group of control-injected knees, fluorescence intensity did not change significantly during the 21-day period after injection. However, within the group of MIA-injected joints, fluorescence intensity decreased by 29% from day 1 to day 11 after injection (P Ͻ 0.05) and further decreased by 54% from day 11 to day 21 (P Ͻ 0.05), reaching the level observed in control knees ( Figure 4B ).
Three weeks after injection of MIA to induce OA, vascularization in both knee joints and distal femora was assessed. Sagittal attenuation maps demonstrated erosions on the subchondral bone surfaces of the patella, femur, and tibia in the OA knee joints ( Figure  5A ). The main blood vessels perfused with contrast agent had higher attenuation than the surrounding bone tissue. The 3-D vascular network surrounding the knee joint, including all combined capsule, subchondral and trabecular bone, synovium, and meniscal tissues, is shown in Figure 5B . In the decalcified vascularity maps shown in Figure 5C , the 3-D vascular distribution in the whole knee joint is demonstrated more clearly because mineral has been cleared and surrounding tissues are depicted transparently. Vessel volume, vessel volume fraction, and vessel connectivity density were 27% (P Ͻ 0.05), 16% (P Ͻ 0.05), and 44% (P Ͻ 0.01) higher, 
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XIE ET AL respectively, in the MIA-injected OA knee joints than in the contralateral control joints (Figures 5G-I ). Attenuation maps of sagittal sections of the decalcified distal femur are shown in Figure 5D . Segmented images of the vasculature with surrounding tissues depicted transparently are shown in Figures 5E and F . Quantitative results were similar to results from the whole knee joint. Vessel volume, vessel volume fraction, and vessel connectivity density were 34%, 30%, and 60% higher, respectively, in the OA distal femora than in the control femora (all P Ͻ 0.05) (Figures 5J-L) .
DISCUSSION
Current techniques for evaluation of OA in animal models, such as histologic scoring and biochemical assays, require specimen destruction, are time consuming, and cannot be used to assess the 3-D spatial morphology of articular cartilage and blood vessels. Cartilage histologic scoring methods require scoring of ϳ10 sections across the whole knee joint, and the semiquantitative scores are subjective, with intra-and interobserver variation (25, 26) . Three-dimensional morphometric analysis of images by CT offers distinct advantages compared with 2-D histomorphometry, e.g., eliminating the need for exact specimen positioning and alignment (27) , eliminating possible artifacts caused by sample fixation, dehydration, embedding, and sectioning (28) , and providing more precise thickness measurements via sphere fitting and more complete quantitative volumetric assessments (29, 30) . Following nondestructive CT scanning with Hexabrix or Microfil contrast agents, most standard histologic processes (e.g., Safranin O staining in this study) can still be performed.
Microfocal CT enables 3-D quantitative morphologic analysis of hard tissues at micron-level voxel resolutions and has been used to monitor progressive changes in the subchondral bone of rats injected with MIA (31). As MIA-induced OA is not a surgically induced mechanical instability model of the disease, joints were not expected to exhibit subchondral sclerosis or thickening of the subchondral bone plate, which has been observed in guinea pigs with spontaneous OA (32), rabbits with meniscectomy-induced OA (33), rats with anterior cruciate ligament transection (7), mice with spontaneous OA (34) , and human OA patients (35, 36) . Previous studies have demonstrated thinner trabeculae in mice with MIA-or collagenase-induced OA (37, 38) . However, it was still surprising that only 1 week postinjection, there were significant decreases in trabecular bone volume fraction and trabecular thickness in femoral epiphyses. The exact mechanism of the decrease in trabeculae is unknown, but potential causes may be skeletal disuse, inflammation, ROS, and activation of osteoclasts (37) . It has been shown that locomotor activity significantly decreases after MIA injection (20) due to the severe pain induced by inflammation in the MIA-injected OA knee joint (39) . Accordingly, our results suggest that the change in trabecular volume fraction could provide a sensitive and quantitative index of disuse and pain.
Our previous studies indicated that EPIC-CT imaging enables nondestructive assessment of cartilage morphology and composition in rat articular cartilage, with high precision and accuracy (22, 24) . In the present study, we were able to use EPIC-CT to quantitatively depict the temporal changes in 3-D cartilage morphology and composition in the rat distal femora in an MIA-induced OA model. MIA inhibits the activity of G3PDH in chondrocytes, resulting in disruption of glycolysis and eventually, cell death (39) . Destructive enzymatic activity causes proteoglycan degradation, chondrocyte necrobiosis, and disruption of the collagen network, resulting in progressive impairment of mechanical function (40) (41) (42) (43) . This interaction between biochemical and mechanical factors created a progressive cycle of cartilage degradation and subchondral bone loss. The decreases in cartilage volume, area, thickness, and sGAG content were accompanied by loss of trabecular bone and erosion of subchondral bone surface in the distal femora, and these changes detected by CT corresponded to the results of histologic evaluation. The ability to combine standard CT and EPIC-CT to quantitatively analyze cartilage and bone from the same joint provided improved understanding of the interactions between cartilage and bone during the progression of OA.
Reactive oxygen species (superoxide and the hydroxyl radical) are toxic and could play an important role in the initiation and pathophysiology of OA (44) . Currently used fluorescent probes, such as dihydroethidium, have several problems that limit their wider application. Our group has developed a novel class of fluorescent sensors, hydrocyanines, that can be used to image ROS in vivo (45, 46) . Hydrocyanines have nanomolar sensitivity toward the hydroxyl radical with a linear response and are significantly more sensitive than the previous dihydroethidium probes. Using this technique in the present study, the fluorescence intensity we observed in knees with MIA-induced OA indicated that high levels of ROS were present in the synovial capsule 1 day after MIA injection and were gradually relieved by 21 days. This study demonstrates that in vivo fluorescence imaging can be used to noninvasively quantify ROS during OA progression and to assess the efficacy of pharmacologic interventions in small animals. Additionally, the use of hydrocyanines to image ROS has the potential to be a powerful clinical tool in diagnosing OA and monitoring treatment efficacy in humans.
Demonstration of the perfusion of a radiodense contrast agent into blood vessels has allowed indirect nondestructive imaging of 3-D vascularity such that vascular volume, vessel thickness, and connectivity density can be quantified postmortem (47) (48) (49) (50) . In this study we have shown that CT with contrast agent perfusion could be utilized to quantify 3-D vascularity in a small animal OA model, providing evidence, for the first time, of higher vascularity in OA-affected whole knee joints and distal femora. These findings suggest the importance of angiogenesis in the progression of OA, consistent with results showing that vascular invasion into subchondral bone contributes to cartilage degradation by inducing expression of matrix metalloproteinases in OA (51) . Although the exact mechanisms of angiogenesis in OA are still not clear, the high levels of ROS and early synovial inflammation indicated by joint swelling on day 1 postinjection are thought to play an important role in this pathologic regeneration (16) . ROS can induce VEGF expression (52) , which may stimulate angiogenesis, and increased VEGF expression has been detected as early as 1 week after surgery in the rat OA model (12, 53) . The combination of angiogenesis and ROS might also exacerbate the progression of cartilage degeneration and bone remodeling (17, 18, 54) .
Providing a methodology that enables the creation of 3-D articular cartilage thickness and topography maps may impact many relevant applications. Using high-resolution 3-D cartilage thickness maps, focal variations in cartilage thickness can be visualized with a color scale, and the cartilage contact area and surface stresses can be estimated (29, 55) . Thickness and topography maps can also be used to evaluate joint mechanics and mechanoadaptation of articular cartilage (56) . In addition, these maps could be utilized to define the relationship between genetic background and cartilage phenotype (37) and to provide guidance in the design of prosthetic surfaces and tissue engineering constructs.
The MIA OA model is minimally invasive, reproducibly induces OA-like lesions, and has been widely used in OA animal studies (20, 31, 57, 58) . One of the limitations of the present study was the use of salineinjected contralateral limbs as controls rather than using naive, age-matched control animals. The mobility of mice with MIA decreased while loading of the contralateral limbs increased compared with the MIA-injected limbs (20) , suggesting that the contralateral limb may not be truly normal. In this study, histologic analysis of the contralateral femora showed no apparent pathologic changes in bone or cartilage, supporting the use of contralateral limbs as an internal control. Nevertheless, inclusion of age-matched control animals could provide additional insights into specific effects of MIA. MIAinduced arthritis is an aggressive model of cartilage degeneration and subchondral bone remodeling and is suitable for evaluating ROS, inflammation, pain, and angiogenesis during OA progression. However, the aggressiveness of this model limited our ability to elaborate on the relationship between cartilage degeneration and subchondral bone remodeling during early OA initiation in the present study. Further research is needed to study multiple tissues via these novel techniques in the setting of more gradually progressive disease, e.g., spontaneous or surgically induced OA, which are more similar to early OA in humans.
In summary, this is the first study to quantify the temporal changes in articular cartilage, subchondral bone, ROS, and vascularization via fluorescence imaging and contrast-enhanced CT in a rat model of MIAinduced OA. The ability to quantitatively evaluate changes in multiple tissues during the initiation and progression of OA may improve our understanding of the interactive changes in multiple tissues in OA pathophysiology and provide insights for development of new treatment modalities. These advanced imaging techniques have the potential to become standardized analysis methods for comprehensive evaluation of articular joint degeneration and treatment efficacy.
